1. Home
  2. GKOS vs CBT Comparison

GKOS vs CBT Comparison

Compare GKOS & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CBT
  • Stock Information
  • Founded
  • GKOS 1998
  • CBT 2019
  • Country
  • GKOS United States
  • CBT United States
  • Employees
  • GKOS N/A
  • CBT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CBT Major Chemicals
  • Sector
  • GKOS Health Care
  • CBT Industrials
  • Exchange
  • GKOS Nasdaq
  • CBT Nasdaq
  • Market Cap
  • GKOS 5.1B
  • CBT 4.3B
  • IPO Year
  • GKOS 2015
  • CBT N/A
  • Fundamental
  • Price
  • GKOS $89.91
  • CBT $73.90
  • Analyst Decision
  • GKOS Strong Buy
  • CBT Hold
  • Analyst Count
  • GKOS 13
  • CBT 3
  • Target Price
  • GKOS $135.15
  • CBT $92.67
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • CBT 488.5K
  • Earning Date
  • GKOS 04-30-2025
  • CBT 05-05-2025
  • Dividend Yield
  • GKOS N/A
  • CBT 2.44%
  • EPS Growth
  • GKOS N/A
  • CBT N/A
  • EPS
  • GKOS N/A
  • CBT 7.72
  • Revenue
  • GKOS $404,523,000.00
  • CBT $3,908,000,000.00
  • Revenue This Year
  • GKOS $27.84
  • CBT $3.20
  • Revenue Next Year
  • GKOS $27.88
  • CBT $3.44
  • P/E Ratio
  • GKOS N/A
  • CBT $9.56
  • Revenue Growth
  • GKOS 23.92
  • CBT N/A
  • 52 Week Low
  • GKOS $77.10
  • CBT $71.64
  • 52 Week High
  • GKOS $163.71
  • CBT $117.46
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • CBT 37.23
  • Support Level
  • GKOS $84.26
  • CBT $71.64
  • Resistance Level
  • GKOS $92.27
  • CBT $78.85
  • Average True Range (ATR)
  • GKOS 3.94
  • CBT 2.12
  • MACD
  • GKOS 0.57
  • CBT -0.35
  • Stochastic Oscillator
  • GKOS 58.87
  • CBT 21.50

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.

Share on Social Networks: